石四药集团(02005)：盐酸贝尼地平片获得药品生产注册批件

Core Viewpoint - The company, Stone Four Pharmaceutical Group, has received the drug production registration approval from the National Medical Products Administration of China for its Benidipine Hydrochloride Tablets (8mg), which is classified as a Class 4 chemical drug and is considered to have passed the consistency evaluation [1] Group 1 - The Benidipine Hydrochloride Tablets are primarily used for the treatment of essential hypertension and angina pectoris [1] - The company's raw material for Benidipine has also been approved by the National Medical Products Administration for registration as a raw material for use in marketed formulations [1]